Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

NCT00440297 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B Virus Infection

Interventions

BIOLOGICAL: Comparator: modified process hepatitis B vaccine
BIOLOGICAL: Comparator: ENGERIX-B™

Sponsor

Merck Sharp & Dohme LLC